Tag: Philips Respironics

All

Philips Gradually Re-Enters CPAP Markets

Customers are welcoming Philips Respironics CPAP devices back in markets around the globe, according to Philips CEO Roy Jakobs.

All

FDA: Philips CPAP Recall Testing Inadequate to Fully Evaluate Risks

The FDA has requested Philips conduct additional testing on its recalled CPAP, BiPAP, and ventilator devices, calling testing to date inadequate to fully evaluate the risks posed to users.

All

Canadian Philips CPAP Class Action Handed Over to Law Firm Consortium

The national consortium of law firms will advance the carriage of a class action related to the recall of Philips’ CPAP and ventilator devices.

Philips: Sleep Therapy Devices Pass Ozone Cleaning Analysis

Aug 7, 2023 | CPAP & PAP Devices, Sleep Safety

Philips Respironics provided the latest results and conclusions on the comprehensive test and research program to assess potential health risks related to the polyester-based polyurethane sound abatement foam in specific sleep therapy and ventilator devices under the voluntary June 2021 recall.

Philips: ‘99%’ of Replacement Sleep Therapy Devices Produced

Jul 24, 2023 | CPAP & PAP Devices, Obstructive Sleep Apnea, Sleep Safety, Ventilation Therapies - ASV

Philips Respironics provided an update on the field action for specific sleep therapy and ventilator devices involved in the company’s ongoing recall.

40 More Deaths Reported in Philips Recall

Jun 2, 2023 | CPAP & PAP Devices, FDA, Sleep Safety

The FDA updated its Philips Respironics recall safety communication to provide updated information about medical device reports that the agency received from Jan 1 to March 31.

Philips Completes Risk Assessments for Recalled CPAPs and BiPAPs

May 16, 2023 | CPAP & PAP Devices, Sleep Safety

Royal Philips’ CEO says the third-party risk assessments for the sleep therapy devices under the June 2021 recall are “positive and reassuring.”

Philips CEO: Resolving Recall Remains ‘Our Highest Priority’

Apr 24, 2023 | CPAP & PAP Devices, FDA, Sleep Safety

Philips provides an update on field action for specific sleep therapy and ventilator devices involved in the company’s ongoing recall.

Sleep Medicine Tied to Top Health Tech Hazard of 2023

Apr 13, 2023 | CPAP & PAP Devices, Sleep Safety

ECRI released its annual Top 10 Health Technology Hazards report, and its biggest safety concern directly relates to sleep medicine.

Philips Taps Former Pear Exec as Chief Business Leader

Mar 15, 2023 | Connected Care, Recruiting & Hiring

Royal Philips announced a new chief business leader for its connected care businesses, bringing on a seasoned healthcare leader with experience in the sleep space.

91 More Reports of Death in Philips Recall-Related Reporting

Nov 30, 2022 | CPAP & PAP Devices, FDA

The FDA updated its safety communication on the Philips’ recall to include reporting of medical device reports received from August 1 to October 31, 2022.

How Dentists Are Faring Amid the Philips Recall and CPAP Shortages

Nov 18, 2022 | Oral Appliances

When Philips Respironics issued a CPAP recall affecting millions of patients, sleep physicians and patients alike scrambled to identify alternative treatments for sleep apnea. Many of them found a solution in oral appliance therapy.

A Potentially Huge CPAP Pressure Mistake

Nov 16, 2022 | CPAP & PAP Devices, Obstructive Sleep Apnea

New data suggests suggest CPAP pressure relief might be best placed where we least expect it.

Philips to Cut 4,000 Positions to Streamline Work and Reduce Expenses

Oct 24, 2022 | CPAP & PAP Devices

Philips has initiated productivity actions, including simplifying the organization to streamline the way of working and reduce expenses.

FDA: Philips Respironics Recall Classified as Level I

Oct 19, 2022 | CPAP & PAP Devices

The new classification comes after the FDA announced a Philips Respironics recall of certain BiPAP and CPAP masks due to a serious safety concern related to magnetic headgear clips that may cause harm to people who have implanted medical devices.

Philips Warns of Lower-Than-Forecast Sales for Q3 2022 Due to Supply Chain Challenges

Oct 14, 2022 | CPAP & PAP Devices

Philips’ performance in the third quarter was impacted by continued supply chain challenges that were more significant than anticipated.

Philips Recalls Specific CPAP, BiPAP Masks with Magnets

Sep 6, 2022 | CPAP & PAP Devices, FDA

The FDA announced the recall of certain Philips Respironics CPAP and BiPAP masks due to a safety concern involving magnets.

Philips Respironics to Pay $24M to Settle Claims of Kickbacks to DMEs

Sep 1, 2022 | CPAP & PAP Devices, Fraud & Malpractice

The settlement resolves a lawsuit originally brought by a Respironics’ employee under the whistleblower provisions of the False Claims Act.

1
...
2
3
4
5
6
7
8
9
10
11
12
13
14
15
...
16